CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
-
* Corresponding author: Francisco J Esteva festeva@mdanderson.org
Breast Cancer Research 2007, 9:R87 doi:10.1186/bcr1836
Accesses
- Last 30 days: 67 accesses
- Last year: 656 accesses
- All time: 4083 accesses
Cited by
BioMed Central: 1 citation
|
Review
Molecular targeted therapies for breast cancer treatment Claus M Schlotter, Ulf Vogt, Heike Allgayer, Burkhard Brandt Breast Cancer Research 2008, 10:211 (24 July 2008) |
